Literature DB >> 28496804

Atrial Fibrillation in Patients with Ischemic and Non-Ischemic Left Ventricular Dysfunction.

Robin Ducas1, Vignendra Ariyarajah2.   

Abstract

Atrial fibrillation (AF) and left ventricular dysfunction (LVD) are increasingly common clinical problems, affecting millions of people worldwide. It is well established that the presence of AF portends a poor prognosis in the setting of both ischemic and non-ischemic LVD, and frequently results in worsening clinical status. Many clinical studies and trials have attempted to address treatment options and efficacy; despite this treatment for AF in LVD is still controversial.

Entities:  

Year:  2013        PMID： 28496804      PMCID： PMC5153099          DOI： 10.4022/jafib.535

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN： 1941-6911


  40 in total

1.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

Authors:  Isabelle C Van Gelder; Vincent E Hagens; Hans A Bosker; J Herre Kingma; Otto Kamp; Tsjerk Kingma; Salah A Said; Julius I Darmanata; Alphons J M Timmermans; Jan G P Tijssen; Harry J G M Crijns
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

2.  The incidence and prognostic significance of new-onset atrial fibrillation in patients with acute myocardial infarction and left ventricular systolic dysfunction: a CARISMA substudy.

Authors:  Christian Jons; Uffe G Jacobsen; Rikke Moerch Joergensen; Niels Thue Olsen; Ulrik Dixen; Arne Johannessen; Heikki Huikuri; Marc Messier; Scott McNitt; Poul Erik Bloch Thomsen
Journal:  Heart Rhythm       Date:  2010-11-18       Impact factor: 6.343

Review 3.  Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy.

Authors:  William H Maisel; Lynne Warner Stevenson
Journal:  Am J Cardiol       Date:  2003-03-20       Impact factor: 2.778

4.  Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.

Authors:  Lars G Olsson; Karl Swedberg; Anique Ducharme; Christopher B Granger; Eric L Michelson; John J V McMurray; Margareta Puu; Salim Yusuf; Marc A Pfeffer
Journal:  J Am Coll Cardiol       Date:  2006-04-27       Impact factor: 24.094

5.  Incidence of and risk factors for atrial fibrillation in older adults.

Authors:  B M Psaty; T A Manolio; L H Kuller; R A Kronmal; M Cushman; L P Fried; R White; C D Furberg; P M Rautaharju
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

6.  Catheter ablation for atrial fibrillation in congestive heart failure.

Authors:  Li-Fern Hsu; Pierre Jaïs; Prashanthan Sanders; Stéphane Garrigue; Mélèze Hocini; Fréderic Sacher; Yoshihide Takahashi; Martin Rotter; Jean-Luc Pasquié; Christophe Scavée; Pierre Bordachar; Jacques Clémenty; Michel Haïssaguerre
Journal:  N Engl J Med       Date:  2004-12-02       Impact factor: 91.245

7.  Increased mortality after dronedarone therapy for severe heart failure.

Authors:  Lars Køber; Christian Torp-Pedersen; John J V McMurray; Ole Gøtzsche; Samuel Lévy; Harry Crijns; Jan Amlie; Jan Carlsen
Journal:  N Engl J Med       Date:  2008-06-19       Impact factor: 91.245

8.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

9.  Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study.

Authors:  S M Vaziri; M G Larson; E J Benjamin; D Levy
Journal:  Circulation       Date:  1994-02       Impact factor: 29.690

10.  Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction.

Authors:  D L Dries; D V Exner; B J Gersh; M J Domanski; M A Waclawiw; L W Stevenson
Journal:  J Am Coll Cardiol       Date:  1998-09       Impact factor: 24.094
View more
  1 in total

1.  Characterization of a porcine model of atrial arrhythmogenicity in the context of ischaemic heart failure.

Authors:  Sebastian Clauss; Dominik Schüttler; Christina Bleyer; Julia Vlcek; Mehdi Shakarami; Philipp Tomsits; Sarah Schneider; Florian Maderspacher; Kavi Chataut; Anna Trebo; Christine Wang; Jan Kleeberger; Ruibing Xia; Elisabeth Baloch; Bianca Hildebrand; Steffen Massberg; Reza Wakili; Stefan Kääb
Journal:  PLoS One       Date:  2020-05-04       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.